These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 33691907)

  • 21. GPCR-mediated YAP/TAZ inactivation in fibroblasts via EPAC1/2, RAP2C, and MAP4K7.
    Choi KM; Haak AJ; Diaz Espinosa AM; Cummins KA; Link PA; Aravamudhan A; Wood DK; Tschumperlin DJ
    J Cell Physiol; 2021 Nov; 236(11):7759-7774. PubMed ID: 34046891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Piezo1 mediates endothelial atherogenic inflammatory responses via regulation of YAP/TAZ activation.
    Yang Y; Wang D; Zhang C; Yang W; Li C; Gao Z; Pei K; Li Y
    Hum Cell; 2022 Jan; 35(1):51-62. PubMed ID: 34606042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyaluronan-Based Gel Promotes Human Dental Pulp Stem Cells Bone Differentiation by Activating YAP/TAZ Pathway.
    La Noce M; Stellavato A; Vassallo V; Cammarota M; Laino L; Desiderio V; Del Vecchio V; Nicoletti GF; Tirino V; Papaccio G; Schiraldi C; Ferraro GA
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The YAP-TEAD4 complex promotes tumor lymphangiogenesis by transcriptionally upregulating CCBE1 in colorectal cancer.
    Song J; Dang X; Shen X; Liu Y; Gu J; Peng X; Huang Z; Hong W; Cui L; Liu CY
    J Biol Chem; 2023 Apr; 299(4):103012. PubMed ID: 36781122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights into the Hippo/YAP pathway in idiopathic pulmonary fibrosis.
    Sun M; Sun Y; Feng Z; Kang X; Yang W; Wang Y; Luo Y
    Pharmacol Res; 2021 Jul; 169():105635. PubMed ID: 33930530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of Hippo-YAP/TAZ signalling in intervertebral disc degeneration.
    Zheng-Wei S; Yuan T; Chao-Shuai F; Lei Z; Zong-Rang S; Tuan-Jiang L; Ding-Jun H
    Biomed Pharmacother; 2023 Mar; 159():114099. PubMed ID: 36641923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges.
    Kumar A; BharathwajChetty B; Manickasamy MK; Unnikrishnan J; Alqahtani MS; Abbas M; Almubarak HA; Sethi G; Kunnumakkara AB
    Pharmacol Res; 2024 May; 203():107167. PubMed ID: 38599470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined control of the fibroblast contractile program by YAP and TAZ.
    Link PA; Choi KM; Diaz Espinosa AM; Jones DL; Gao AY; Haak AJ; Tschumperlin DJ
    Am J Physiol Lung Cell Mol Physiol; 2022 Jan; 322(1):L23-L32. PubMed ID: 34755530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YAP/TAZ axis was involved in the effects of metformin on breast cancer.
    Xu Y; Cai H; Xiong Y; Tang L; Li L; Zhang L; Shen Y; Yang Y; Lin L; Huang J
    J Chemother; 2023 Nov; 35(7):627-637. PubMed ID: 36656142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer.
    Cunningham R; Hansen CG
    Clin Sci (Lond); 2022 Feb; 136(3):197-222. PubMed ID: 35119068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Multiple Interactions of RUNX with the Hippo-YAP Pathway.
    Chuang LSH; Ito Y
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic Hedgehog-Smoothened Signaling Depends on YAP1‒TAZ/TEAD Transcription to Restrain Differentiation in Basal Cell Carcinoma.
    Yuan Y; Salinas Parra N; Chen Q; Iglesias-Bartolome R
    J Invest Dermatol; 2022 Jan; 142(1):65-76.e7. PubMed ID: 34293352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis.
    Boopathy GTK; Hong W
    Front Cell Dev Biol; 2019; 7():49. PubMed ID: 31024911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-β/Smads signaling pathway, Hippo-YAP/TAZ signaling pathway, and VEGF: Their mechanisms and roles in vascular remodeling related diseases.
    Liu H; Sun M; Wu N; Liu B; Liu Q; Fan X
    Immun Inflamm Dis; 2023 Nov; 11(11):e1060. PubMed ID: 38018603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Hippo Pathway Effector YAP Promotes Ferroptosis via the E3 Ligase SKP2.
    Yang WH; Lin CC; Wu J; Chao PY; Chen K; Chen PH; Chi JT
    Mol Cancer Res; 2021 Jun; 19(6):1005-1014. PubMed ID: 33707306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, Synthesis and Evaluation of a Series of 1,5-Diaryl-1,2,3-triazole-4-carbohydrazones as Inhibitors of the YAP-TAZ/TEAD Complex.
    Gibault F; Sturbaut M; Coevoet M; Pugnière M; Burtscher A; Allemand F; Melnyk P; Hong W; Rubin BP; Pobbati AV; Guichou JF; Cotelle P; Bailly F
    ChemMedChem; 2021 Sep; 16(18):2823-2844. PubMed ID: 34032019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations.
    Cunningham R; Jia S; Purohit K; Salem O; Hui NS; Lin Y; Carragher NO; Hansen CG
    Clin Transl Med; 2023 Feb; 13(2):e1190. PubMed ID: 36740402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hippo/YAP signaling pathway protects against neomycin-induced hair cell damage in the mouse cochlea.
    Wang M; Dong Y; Gao S; Zhong Z; Cheng C; Qiang R; Zhang Y; Shi X; Qian X; Gao X; Guan B; Yu C; Yu Y; Chai R
    Cell Mol Life Sci; 2022 Jan; 79(2):79. PubMed ID: 35044530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry.
    Azad T; Ghahremani M; Yang X
    Cells; 2019 May; 8(5):. PubMed ID: 31052445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.